Logo Image
News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions PodcastShorts
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPartnersPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksState of the ScienceWhitepapers

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
Advertisement

Dow Chemical

Advertisement

Articles by Dow Chemical

Particulates, Endotoxins, and Bioburden Characterization of Silicone Tubing for Biopharmaceutical Applications

ByDow Chemical
February 13th 2018

Enhancing the Solubility of Poorly Soluble Drugs

ByDow Chemical
February 12th 2018

Enhancing the Solubility of Poorly Soluble Drugs

ByDow Chemical
January 2nd 2018
Advertisement

Latest Updated Articles

  • Enhancing the Solubility of Poorly Soluble Drugs
    Enhancing the Solubility of Poorly Soluble Drugs

    January 2nd 2018

  • Enhancing the Solubility of Poorly Soluble Drugs
    Enhancing the Solubility of Poorly Soluble Drugs

    February 12th 2018

  • Particulates, Endotoxins, and Bioburden Characterization of Silicone Tubing for Biopharmaceutical Applications
    Particulates, Endotoxins, and Bioburden Characterization of Silicone Tubing for Biopharmaceutical Applications

    February 13th 2018



Advertisement
Advertisement

Trending on Pharmaceutical Technology

1

PharmTech Weekly Roundup—June 5, 2026

2

Leveraging an Innovative Mid-Scale Manufacturing Solution to Meet Diverse Needs

3

Tom Sellig on CDMO Innovation and US Manufacturing Growth

4

Renewing Prosaic Generics for Cancer Treatment

5

Viral Safety 2.0: Plant-Ready Actions for ICH Q5A(R2) Compliance

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us